(Q39378771)

English

Protection by cilostazol against amyloid-β(1-40)-induced suppression of viability and neurite elongation through activation of CK2α in HT22 mouse hippocampal cells

scientific article published on 16 March 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Protection by cilostazol against amyloid-β(1-40)-induced suppression of viability and neurite elongation through activation of CK2α in HT22 mouse hippocampal cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

based on heuristic

inferred from title

author name string

Hye Rin Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

So Youn Park

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Hye Young Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Hwa Kyoung Shin

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Won Suk Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Byung Yong Rhim

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Ki Whan Hong

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Chi Dae Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

16 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Journal of Neuroscience Research

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

90

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1566-1576

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

Activation of casein kinase II and inhibition of phosphatase and tensin homologue deleted on chromosome 10 phosphatase by nerve growth factor/p75NTR inhibit glycogen synthase kinase-3beta and stimulate axonal growth

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic strategies in Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

Neurite outgrowth mediated by translation elongation factor eEF1A1: a target for antiplatelet agent cilostazol

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

Cilostazol: therapeutic potential against focal cerebral ischemic damage

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

Cilostazol enhances casein kinase 2 phosphorylation and suppresses tumor necrosis factor-alpha-induced increased phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and apoptotic cell death in SK-N-SH cells

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

Cilostazol prevents focal cerebral ischemic injury by enhancing casein kinase 2 phosphorylation and suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation in rats

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

Neuroprotection by cilostazol, a phosphodiesterase type 3 inhibitor, against apoptotic white matter changes in rat after chronic cerebral hypoperfusion

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

Concurrent administration of cilostazol with donepezil effectively improves cognitive dysfunction with increased neuroprotection after chronic cerebral hypoperfusion in rats

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

Protein kinase CK2: structure, regulation and role in cellular decisions of life and death

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation.

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

The BH3-only protein Puma is both necessary and sufficient for neuronal apoptosis induced by DNA damage in sympathetic neurons

1 reference

https://api.crossref.org/works/10.1002%2FJNR.23037

21 January 2018

Identifiers

10.1002/JNR.23037

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39378771&oldid=1823569977"